Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation
Not Applicable
Terminated
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT00528307
- Lead Sponsor
- R&D Cardiologie
- Brief Summary
To determine whether Biventricular pacing in patients undergoing HIS bundle ablation for atrial fibrilation has beneficial effects on myocardial perfusion and left ventricularr ejection fraction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
- Normal to nearly normal LVF (EF > 40%)
- Drug-refractory, persistent or permanent atrial fibrillation
- Referred for His ablation
Exclusion Criteria
- Unwilling or unable to sign the informed consent
- Life expectancy < 1year from non-cardiac causes
- Previous myocardial infarction
- Previous coronary bypass surgery
- Poor left ventricle function (EF< 40%) from any cause
- Symptomatic obstructive coronary artery disease
- Poor ultra sound imaging quality.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Difference in size of myocardial perfusion abnormalities in the two treatment groups as measured with MPS. 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie improved myocardial perfusion with biventricular pacing post-HIS bundle ablation?
How does chronic multi-site biventricular pacing compare to right ventricular apex pacing in preserving left ventricular ejection fraction?
Which biomarkers correlate with response to biventricular pacing in patients with drug-refractory atrial fibrillation and normal LV function?
What are the potential adverse events associated with HIS bundle ablation and long-term biventricular pacing strategies?
Are there combination therapies or alternative devices that enhance outcomes compared to standalone HIS bundle ablation for atrial fibrillation?
Trial Locations
- Locations (1)
St Antonius Hospital
🇳🇱Nieuwegein, Utrecht, Netherlands
St Antonius Hospital🇳🇱Nieuwegein, Utrecht, Netherlands